Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2025 Feb 18;26(1):85.
doi: 10.1186/s12882-025-04010-9.

C3 glomerulopathy associated with mycoplasma pneumoniae infection and positive IgA staining

Affiliations
Case Reports

C3 glomerulopathy associated with mycoplasma pneumoniae infection and positive IgA staining

Zhi-Yu Duan et al. BMC Nephrol. .

Abstract

Background: Patients with C3 glomerulopathy (C3G) often have a history of infection, which implies that infection may lead to abnormal activation of the complement alternative pathway (CAP) and induce the development of C3G. However, patients with postinfectious glomerulonephritis (PIGN) often have a low serum C3 concentration and positive glomerular C3 staining, consistent with the activation of the CAP. PIGN, especially if it involves simultaneous IgA deposition, is often difficult to differentiate from C3G.

Case presentation: In this study, we report the consequences of Mycoplasma pneumoniae (MP) infection in a 66-year-old male Chinese patient, who developed persistent hypocomplementemia, gross hematuria, and rapidly progressive glomerulonephritis. The findings of the histologic examination of an initial renal biopsy were consistent with a diagnosis of IgA-dominant postinfectious glomerulonephritis. The sample was negative for Gd-IgA1 staining. After treatment with antibiotics, glucocorticoids, and mycophenolate mofetil, the patient's serum creatinine decreased from a peak of 387 µmol/L to 195 µmol/L prior to discharge, and there was a partial response in his urinary protein concentration. After 2 months, his serum C3 concentration had returned to normal. However, owing to reinfection with MP the patient's serum creatinine rapidly increased again to 475.07 µmol/L, and this was accompanied by a decrease in serum C3 concentration (> 8 months) and positivity for C3 nephritis factor. Examination of both renal biopsies showed stronger immunostaining for C3 than for IgA in the glomeruli.

Conclusion: Thus, MP infection can cause sustained activation of the CAP, leading to C3G. For patients with MP infection, if there is an ongoing decrease in complement C3 levels and a progressive increase in serum creatinine, it is crucial to be vigilant for possible C3G and to consider the use of immunosuppressive therapy in conjunction with anti-infective treatment to prevent the ongoing activation of the CAP.

Keywords: Mycoplasma pneumoniae; Acute kidney injury; C3 glomerulopathy; IgA-dominant postinfectious glomerulonephritis; Renal biopsy.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: Written informed consent to participate obtained from patient. Consent for publication: Written informed consent for publication obtained from patient. Competing interests: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Histological findings for the first renal biopsy. (A) Hematoxylin and eosin (H&E) staining and light microscopic examination (400×) revealed mesangial proliferative glomerulonephritis with crescent formation and red-cell casts in the renal tubules. (B) Periodic acid-Schiff staining (400×). (C) Periodic acid-Schiff-methenamine silver staining (400×). (D) Electron microscopy revealed blocky electron dense deposits in the mesangial area, segmental subcutaneous tissue, and segmental basement membrane (8,000×). (E) Electron microscopy revealed “hump-like” subepithelial immune-complex deposition (10,000×). (F-I) The glomeruli were positive for C3, IgA, kappa, and lambda (400×)
Fig. 2
Fig. 2
Immunostaining for Gd-IgA1 in renal biopsy specimen. (A) Staining for IgA in a glomerulus from the present patient (400×). (B) Staining for Gd-IgA1 in the present patient (400×). (C) Staining for IgA in a glomerulus from a patient with primary IgAN (400×). (D) Staining for Gd-IgA1 in a renal biopsy from a patient with primary IgAN (400×)
Fig. 3
Fig. 3
Histological findings for the second renal biopsy. (A) Hematoxylin and eosin (H&E) staining (200×). (B) Periodic acid-Schiff staining (200×). (C) Periodic acid-Schiff-methenamine silver staining (200×). (D) Staining for C3 of a glomerulus from the present patient (400×). (E) Staining for IgA of a glomerulus from the present patient (400×)
Fig. 4
Fig. 4
The time series graph of the course of the disease

References

    1. Fakhouri F, Fremeaux-Bacchi V, Noel LH, Cook HT, Pickering MC. C3 glomerulopathy: a new classification. Nat Rev Nephrol. 2010;6(8):494–9. - PubMed
    1. Pickering MC, D’Agati VD, Nester CM, Smith RJ, Haas M, Appel GB, et al. C3 glomerulopathy: consensus report. Kidney Int. 2013;84(6):1079–89. - PMC - PubMed
    1. Ravindran A, Fervenza FC, Smith RJH, De Vriese AS, Sethi S. C3 Glomerulopathy: Ten Years’ Experience at Mayo Clinic. Mayo Clin Proc. 2018;93(8):991–1008. - PMC - PubMed
    1. Fakhouri F, Le Quintrec M, Fremeaux-Bacchi V. Practical management of C3 glomerulopathy and Ig-mediated MPGN: facts and uncertainties. Kidney Int. 2020;98(5):1135–48. - PubMed
    1. Noris M, Daina E, Remuzzi G. Membranoproliferative glomerulonephritis: no longer the same disease and may need very different treatment. Nephrol Dial Transpl. 2023;38(2):283–90. - PubMed

Publication types

LinkOut - more resources